Viewing Study NCT02293005

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-02-22 @ 3:04 AM
Study NCT ID: NCT02293005
Status: COMPLETED
Last Update Posted: 2022-10-04
First Post: 2014-11-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mesothelioma View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung Cancer View
None Mesothelioma View
None Unresectable malignant pleural mesothelioma View
None MPM View
None Alisertib View
None MLN8237 View